1. Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies
- Author
-
López-Moreno, Ana, Acuña, Inmaculada, Torres-Sánchez, Alfonso, Ruiz-Moreno, Ángel, Cerk, Klara, Rivas, Ana, Suárez, Antonio, Monteoliva-Sánchez, Mercedes, Aguilera, Margarita, [López-Moreno,A, Torres-Sánchez,A, Ruiz-Moreno,A, Cerk,K, Monteoliva-Sánchez,M, Aguilera,M] Department of Microbiology, Faculty of Pharmacy, Campus of Cartuja, University of Granada,Granada, Spain. [López-Moreno,A, Acuña,I, Suárez,A, Aguilera,M] Center of Biomedical Research, Institute of Nutrition and Food Technology 'José Mataix', University of Granada, Armilla, Granada, Spain. [Acuña,I, Suárez,A] Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Campus of Cartuja, University of Granada, Granada, Spain. [Rivas,A, Aguilera,M] IBS, Instituto de Investigación Biosanitaria, Granada, Spain. [Rivas,A] Department of Nutrition and Food Science, Campus of Cartuja, University of Granada, Granada, Spain, and This work was carried out within the frame of GP/EFSA/ENCO/380 2018/03/G04: OBEMIRISK: Knowledge platform for assessing the risk of Bisphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers. This research was also funded by FEDER Infrastructure: IE_2019-198. A.L-M Incentivación de la Investigación. Plan Propio-UGR. K. Cerk is collaborating with UGR under the EU-FORA Programme (2020/2021).
- Subjects
Phenomena and Processes::Genetic Phenomena::Phenotype [Medical Subject Headings] ,Endobolome ,Technology and Food and Beverages::Food and Beverages::Food::Dietary Supplements::Probiotics [Medical Subject Headings] ,Endocrine pathogenesis ,Disbiosis ,Next-generation probiotics ,Probióticos ,Obesidad ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology, Social::Life Style [Medical Subject Headings] ,Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet [Medical Subject Headings] ,Organisms::Bacteria::Gram-Positive Bacteria::Actinobacteria::Bifidobacterium [Medical Subject Headings] ,Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings] ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,Organisms::Bacteria::Gram-Positive Bacteria::Lactobacillales::Lactobacillaceae::Lactobacillus [Medical Subject Headings] ,Lactobacillus ,Dietary obesogens exposure ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Clinical Laboratory Techniques::Microbiological Techniques::Bacteriological Techniques [Medical Subject Headings] ,Dysbiosis ,Obesity ,Bifidobacterium ,Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Dysbiosis [Medical Subject Headings] ,Culturing - Abstract
The combination of diet, lifestyle, and the exposure to food obesogens categorized into "microbiota disrupting chemicals" (MDC) could determine obesogenic-related dysbiosis and modify the microbiota diversity that impacts on individual health-disease balances, inducing altered pathogenesis phenotypes. Specific, complementary, and combined treatments are needed to face these altered microbial patterns and the specific misbalances triggered. In this sense, searching for next-generation beneficial microbes or next-generation probiotics (NGP) by microbiota culturing, and focusing on their demonstrated, extensive scope and well-defined functions could contribute to counteracting and repairing the effects of obesogens. Therefore, this review presents a perspective through compiling information and key strategies for directed searching and culturing of NGP that could be administered for obesity and endocrine-related dysbiosis by (i) observing the differential abundance of specific microbiota taxa in obesity-related patients and analyzing their functional roles, (ii) developing microbiota-directed strategies for culturing these taxa groups, and (iii) applying the successful compiled criteria from recent NGP clinical studies. New isolated or cultivable microorganisms from healthy gut microbiota specifically related to obesogens' neutralization effects might be used as an NGP single strain or in consortia, both presenting functions and the ability to palliate metabolic-related disorders. Identification of holistic approaches for searching and using potential NGP, key aspects, the bias, gaps, and proposals of solutions are also considered in this review. Yes
- Published
- 2021